-
2
-
-
0023924034
-
Total knee replacement in haemophilic arthropathy
-
Karthaus RP, Novakova IR. Total knee replacement in haemophilic arthropathy. J Bone Joint Surg Br. 1988;70:382-385.
-
(1988)
J Bone Joint Surg Br
, vol.70
, pp. 382-385
-
-
Karthaus, R.P.1
Novakova, I.R.2
-
4
-
-
0024957209
-
Total knee arthroplasty for the treatment of chronic hemophilic arthropathy
-
Figgie MP, Goldberg VM, Figgie HE, et al. Total knee arthroplasty for the treatment of chronic hemophilic arthropathy. Clin Orthop. 1989;248:98-107.
-
(1989)
Clin Orthop
, vol.248
, pp. 98-107
-
-
Figgie, M.P.1
Goldberg, V.M.2
Figgie, H.E.3
-
8
-
-
0024517337
-
Surgical management of advanced haemophilic arthropathy
-
Luck JV, Kasper CK. Surgical management of advanced haemophilic arthropathy. Clin Orthop. 1988;242:60-82.
-
(1988)
Clin Orthop
, vol.242
, pp. 60-82
-
-
Luck, J.V.1
Kasper, C.K.2
-
9
-
-
0022530223
-
Total knee arthroplasty in chronic hemophilic arthropathy
-
Magone JB, Dennis DA, Weis LD. Total knee arthroplasty in chronic hemophilic arthropathy. Orthopedics. 1986;9:653-657.
-
(1986)
Orthopedics
, vol.9
, pp. 653-657
-
-
Magone, J.B.1
Dennis, D.A.2
Weis, L.D.3
-
10
-
-
0018741305
-
Synovectomy or total replacement of the knee in hemophilia
-
McCollough NC, Enis JE, Lovitt J, et al. Synovectomy or total replacement of the knee in hemophilia. J Bone Joint Surg Br. 1979;61A:69-75.
-
(1979)
J Bone Joint Surg Br
, vol.61 A
, pp. 69-75
-
-
McCollough, N.C.1
Enis, J.E.2
Lovitt, J.3
-
11
-
-
0023013537
-
Long term follow-up of prosthetic joint replacement in hemophilia
-
Rana NA, Shapiro GR, Green D. Long term follow-up of prosthetic joint replacement in hemophilia. Am J Hematol. 1986;23:329-337.
-
(1986)
Am J Hematol
, vol.23
, pp. 329-337
-
-
Rana, N.A.1
Shapiro, G.R.2
Green, D.3
-
13
-
-
0027157982
-
Knee arthroplasty in hemophilia, 5-12 year follow-up of 15 patients
-
Teigland JC, Tjonnfjord GE, Evensen SA, et al. Knee arthroplasty in hemophilia, 5-12 year follow-up of 15 patients. Acta Orthop Scand. 1993;64:153-156.
-
(1993)
Acta Orthop Scand
, vol.64
, pp. 153-156
-
-
Teigland, J.C.1
Tjonnfjord, G.E.2
Evensen, S.A.3
-
15
-
-
0034119502
-
Orthopaedic outcome of total knee replacement in haemophilia A
-
Cohen I, Heim M, Martinowitz U, Chechick A. Orthopaedic outcome of total knee replacement in haemophilia A. Haemophilia. 2000;6:104-109.
-
(2000)
Haemophilia
, vol.6
, pp. 104-109
-
-
Cohen, I.1
Heim, M.2
Martinowitz, U.3
Chechick, A.4
-
16
-
-
0033375490
-
Haemophilic arthropathy: Assessment of quality of life after total knee arthroplasty
-
Schick M, Stucki G, Rodriguez M, et al. Haemophilic arthropathy: assessment of quality of life after total knee arthroplasty. Clin Rheumatol. 1999;18:468-472.
-
(1999)
Clin Rheumatol
, vol.18
, pp. 468-472
-
-
Schick, M.1
Stucki, G.2
Rodriguez, M.3
-
17
-
-
0031662003
-
Total knee and hip arthroplasty in haemophilic patients
-
Heeg M, Meyer K, Smid WM, et al.Total knee and hip arthroplasty in haemophilic patients. Haemophilia. 1998;4:747-751.
-
(1998)
Haemophilia
, vol.4
, pp. 747-751
-
-
Heeg, M.1
Meyer, K.2
Smid, W.M.3
-
18
-
-
0003080028
-
The incidence of factor VIII inhibitors in patients with severe hemophilia A
-
Aledort LM, Hoyer LW, Lusher JM, Reisner HM, White GC II, eds. New York, NY: Plenum Press
-
Hoyer WL. The incidence of factor VIII inhibitors in patients with severe hemophilia A. In: Aledort LM, Hoyer LW, Lusher JM, Reisner HM, White GC II, eds. Inhibitors to Coagulation Factors. New York, NY: Plenum Press; 1995:35-45.
-
(1995)
Inhibitors to Coagulation Factors
, pp. 35-45
-
-
Hoyer, W.L.1
-
19
-
-
0031743504
-
Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery
-
Shapiro AD, Gilchrist GS, Hoots WK, et al. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost. 1998;80:773-778.
-
(1998)
Thromb Haemost
, vol.80
, pp. 773-778
-
-
Shapiro, A.D.1
Gilchrist, G.S.2
Hoots, W.K.3
-
20
-
-
84980312864
-
Inhibitors to factor VIII and IX
-
Brettler D. Inhibitors to factor VIII and IX. Haemophilia. 1995;1:35-39.
-
(1995)
Haemophilia
, vol.1
, pp. 35-39
-
-
Brettler, D.1
-
21
-
-
0032725116
-
Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa
-
Hedner U. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa. Thromb Haemost. 1999;82:531-539.
-
(1999)
Thromb Haemost
, vol.82
, pp. 531-539
-
-
Hedner, U.1
-
22
-
-
0033758876
-
Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors
-
Ingerslev J. Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors. Semin Thromb Hemost. 2000;26:425-432.
-
(2000)
Semin Thromb Hemost
, vol.26
, pp. 425-432
-
-
Ingerslev, J.1
-
23
-
-
0031832066
-
Management of an anti-factor VIII inhibitor occurring during surgical procedure with continuous infusion of Novoseven
-
Menart C, Cognet V, Petit PY, et al. Management of an anti-factor VIII inhibitor occurring during surgical procedure with continuous infusion of Novoseven. Blood Coagul Fibrinolysis. 1998;9:289-290.
-
(1998)
Blood Coagul Fibrinolysis
, vol.9
, pp. 289-290
-
-
Menart, C.1
Cognet, V.2
Petit, P.Y.3
-
24
-
-
0023763216
-
Successful use of recombinant factor VIIa in patients with severe hemophilia A during synovectomy
-
Hedner U, Glazer S, Pingel K, et al. Successful use of recombinant factor VIIa in patients with severe hemophilia A during synovectomy. Lancet. 1988;2:1193.
-
(1988)
Lancet
, vol.2
, pp. 1193
-
-
Hedner, U.1
Glazer, S.2
Pingel, K.3
-
25
-
-
9044244906
-
Major surgery in haemophiliac patients with inhibitors using recombinant factor VIIa
-
Ingerslev J, Freidman D, Gastineau D, et al. Major surgery in haemophiliac patients with inhibitors using recombinant factor VIIa. Haemostasis. 1996;26:18-23.
-
(1996)
Haemostasis
, vol.26
, pp. 18-23
-
-
Ingerslev, J.1
Freidman, D.2
Gastineau, D.3
-
26
-
-
0028356496
-
Successful hemostasis during a major orthopedic operation by using recombinant activated factor VII in a patient with severe hemophilia A and a potent inhibitor
-
O'Marcaigh AS, Schmalz BJ, Shaughnessy WJ, Gilchrist GS. Successful hemostasis during a major orthopedic operation by using recombinant activated factor VII in a patient with severe hemophilia A and a potent inhibitor. Mayo Clin Proc. 1994;69:641-644.
-
(1994)
Mayo Clin Proc
, vol.69
, pp. 641-644
-
-
O'Marcaigh, A.S.1
Schmalz, B.J.2
Shaughnessy, W.J.3
Gilchrist, G.S.4
-
27
-
-
0033758468
-
The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIa
-
Negrier C, Hay CRM. The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIa. Semin Thromb Hemost. 2000;26:407-412.
-
(2000)
Semin Thromb Hemost
, vol.26
, pp. 407-412
-
-
Negrier, C.1
Hay, C.R.M.2
-
28
-
-
0031759475
-
Experiences with continuous infusion of recombinant activated factor VII
-
Schulman S, d'Orion R, Martinowitz U, et al. Experiences with continuous infusion of recombinant activated factor VII. Blood Coagul Fibrinolysis. 1998;9(suppl 1):S97-S101.
-
(1998)
Blood Coagul Fibrinolysis
, vol.9
, Issue.1 SUPPL.
-
-
Schulman, S.1
D'Orion, R.2
Martinowitz, U.3
-
29
-
-
0033060331
-
Recombinant factor VIIa does not induce hypercoagulability in vitro
-
Gallistl S, Cvirn G, Muntean W. Recombinant factor VIIa does not induce hypercoagulability in vitro. Thromb Haemost. 1999;81:245-249.
-
(1999)
Thromb Haemost
, vol.81
, pp. 245-249
-
-
Gallistl, S.1
Cvirn, G.2
Muntean, W.3
-
30
-
-
0033764370
-
The factor VII-platelet interplay: Effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia
-
Monroe DM, Hoffman M, Allen GA, Roberts HR. The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia. Semin Thromb Hemost. 2000;26:373-377.
-
(2000)
Semin Thromb Hemost
, vol.26
, pp. 373-377
-
-
Monroe, D.M.1
Hoffman, M.2
Allen, G.A.3
Roberts, H.R.4
-
31
-
-
0034935085
-
High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system
-
Kjalke M, Ezban M, Monroe DM, et al. High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system. Br J Haematol. 2001;114:114-120.
-
(2001)
Br J Haematol
, vol.114
, pp. 114-120
-
-
Kjalke, M.1
Ezban, M.2
Monroe, D.M.3
-
32
-
-
0017601513
-
Mass-length ratio of fibrin fibers from gel permeation and light scattering
-
Carr ME, Shen LL, Hermans J. Mass-length ratio of fibrin fibers from gel permeation and light scattering. Biopolymers. 1977;16:1-15.
-
(1977)
Biopolymers
, vol.16
, pp. 1-15
-
-
Carr, M.E.1
Shen, L.L.2
Hermans, J.3
-
33
-
-
0017910967
-
Size and density of fibrin fibers from turbidity
-
Carr ME Jr, Hermans J. Size and density of fibrin fibers from turbidity. Macromolecules. 1978;11:46-50.
-
(1978)
Macromolecules
, vol.11
, pp. 46-50
-
-
Carr Jr., M.E.1
Hermans, J.2
-
34
-
-
0024410071
-
Native fibrin gel networks observed by 3D microscopy, permeation and turbidity
-
Blomback B, Carlsson K, Hessel B, et al. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta. 1989;997:96-110.
-
(1989)
Biochim Biophys Acta
, vol.997
, pp. 96-110
-
-
Blomback, B.1
Carlsson, K.2
Hessel, B.3
-
35
-
-
0024241291
-
Strain enhancement of elastic modulus in fine fibrin clots
-
Bale MD, Ferry JD. Strain enhancement of elastic modulus in fine fibrin clots. Thromb Res. 1988;52:565-572.
-
(1988)
Thromb Res
, vol.52
, pp. 565-572
-
-
Bale, M.D.1
Ferry, J.D.2
-
36
-
-
0028156672
-
Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma
-
Carr ME Jr, Zekert SL. Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma. Am J Physiol. 1994;266:H1195-H1201.
-
(1994)
Am J Physiol
, vol.266
-
-
Carr Jr., M.E.1
Zekert, S.L.2
-
37
-
-
0026491075
-
The effect of fibrin structure on fibrinolysis
-
Gabriel DA, Muga K, Boothroyd EM. The effect of fibrin structure on fibrinolysis. J Biol Chem. 1992;267:24259-24263.
-
(1992)
J Biol Chem
, vol.267
, pp. 24259-24263
-
-
Gabriel, D.A.1
Muga, K.2
Boothroyd, E.M.3
-
38
-
-
16044368230
-
Abnormal fibrin structure and inhibition of fibrinolysis in patients with multiple myeloma
-
Carr ME Jr, Dent RM, Carr SL. Abnormal fibrin structure and inhibition of fibrinolysis in patients with multiple myeloma. J Lab Clin Med. 1996;128:83-88.
-
(1996)
J Lab Clin Med
, vol.128
, pp. 83-88
-
-
Carr Jr., M.E.1
Dent, R.M.2
Carr, S.L.3
-
39
-
-
0034022885
-
Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: Dynamic and structural approaches by confocal microscopy
-
Collet JP, Park D, Lesty C, et al. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol. 2000;20:1354-1361.
-
(2000)
Arterioscler Thromb Vasc Biol
, vol.20
, pp. 1354-1361
-
-
Collet, J.P.1
Park, D.2
Lesty, C.3
-
40
-
-
0034977041
-
Clot lysis of variant recombinant fibrinogens confirms that fiber diameter is a major determinant of lysis rate
-
Mullin JL, Norfolk SE, Weisel JW, Lord ST. Clot lysis of variant recombinant fibrinogens confirms that fiber diameter is a major determinant of lysis rate. Ann NY Acad Sci. 2001;936:331-334.
-
(2001)
Ann NY Acad Sci
, vol.936
, pp. 331-334
-
-
Mullin, J.L.1
Norfolk, S.E.2
Weisel, J.W.3
Lord, S.T.4
|